人類絨毛膜促性腺激素分泌(HCG) 市場：依產品類型、治療應用、通路和地區分類。

預計到 2026 年，人類絨毛膜促性腺激素分泌(HCG) 市值將達到 29.6 億美元，到 2033 年將達到 31.2 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 3.68%。

人類絨毛膜促性腺激素分泌(HCG) 是一種受精卵著床後由胎盤分泌的荷爾蒙。這種激素支持卵子的正常發育，並促進卵巢排卵。 HCG 主要用於治療不孕症女性，以誘導排卵。在男性中，它主要用於提高精子數量，也可用於治療因腦下垂體疾病或其他原因導致睪丸未自然下降至陰囊的年輕男性。 HCG 通常透過皮下或肌肉注射給藥。在婦產科醫師或藥師的指導下，HCG 也可在家中自行注射。 HCG 水平可透過尿液檢查或血液檢測進行測量。某些檢測方法可以精確測量其濃度。這些檢測主要用於篩檢，以識別或確認妊娠，或檢測先天性異常。這種荷爾蒙刺激黃體，黃體產生孕酮以維持懷孕。

市場動態

預計市場主要企業擴大採用非內生性成長策略，例如合作和收購，將推動預測期內的市場成長。例如，2021年1月，科技公司默克公司宣布與醫療科技公司皇家飛利浦建立多年合作關係，共同開發用於高度個人化生育治療的臨床級數位化解決方案。

本報告的主要特點

• 本報告對全球人類絨毛膜促性腺激素分泌(HCG) 市場進行了詳細分析，包括市場規模和預測期 (2026-2033) 的複合年成長率，以 2025 年為基準年。
• 此外，它還確定了每個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
• 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
• 本文根據以下參數，介紹了全球人類絨毛膜促性腺激素分泌(HCG) 市場主要企業的概況：公司概況、產品系列、主要亮點、財務績效和策略。
• 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
• 《全球人類絨毛膜促性腺激素分泌(HCG) 市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過分析全球人類絨毛膜促性腺激素分泌(HCG) 市場中使用的各種策略矩陣來促進決策。

目錄

第1章：分析目標與假設

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • PEST分析
  • 波特五力分析
  • 市場機遇
  • 法規環境
  • 主要進展
  • 產業趨勢

第4章 全球人類絨毛膜促性腺激素分泌(HCG) 市場：依產品類型分類 (2026–2033)

• 人類絨毛膜促性腺激素分泌
• 重組人類絨毛膜促性腺激素分泌

第5章 全球人類絨毛膜促性腺激素分泌(HCG) 市場：依治療應用分類 (2026–2033)

• 男性性腺功能低下症
• 女性不孕症的治療
• 少精症的治療
• 隱睪症的治療
• 慢性疼痛
• 其他

第6章 全球人類絨毛膜促性腺激素分泌(HCG) 市場：依通路分類 (2026–2033)

• 醫院藥房
• 零售藥房
• 網路藥房

第7章 全球人類絨毛膜促性腺激素分泌(HCG) 市場：依地區分類 (2026–2033)

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 亞太其他地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第8章 競爭情勢

• 熱圖分析
• 市佔率分析（3x3矩陣）
• 公司簡介
  • Merck &Co., Inc.
  • Ferring BV,Fresenius SE &Co.KGaA
  • Lupin
  • Sun Pharmaceutical Industries Ltd.
  • Lee BioSolutions
  • Serum Institute of India Pvt. Ltd
  • Scripps Laboratories
  • Sanzyme Biologics Pvt. Ltd.
  • VHB Medi Sciences Limited Bharat Serums And Vaccines Limited（BSV）
  • Zydus Lifesciences Ltd
  • Corona Remedies Pvt. Ltd.

第9章 分析師建議

• 機會
• 分析師意見
• Coherent Opportunity Map (COM)

第10章：參考文獻與分析方法

• 參考
• 分析方法

Human Chorionic Gonadotropin (HCG) Market is estimated to be valued at USD 2.96 Bn in 2026 and is expected to reach USD 3.12 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.68% from 2026 to 2033.

Human chorionic gonadotropin (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males, mostly to increase the sperm count and in young boys due to pituitary gland disorders and other diseases, owing to which the testicles of the young males do not drop down naturally into the scrotum. The HCG is usually administered as an injection under the skin into a muscle. The HCG can also be administered at home under the advice of a gynecologist or a pharmacist. The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects. The hormone stimulates the corpus luteum to produce progesterone to maintain the pregnancy.

Market Dynamics

The increasing adoption of inorganic strategies such as partnerships and acquisitions by the key players in the market is expected to drive the market growth over the forecast period. For instance, in January 2021, Merck & Co., Inc., a science and technology company announced a multi-year partnership with Royal Philips, which is a health technology company, to develop clinical-grade digital solutions for highly personalized fertility treatment.

Key features of the study

• This report provides an in-depth analysis of the global human chorionic gonadotropin (HCG) market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global human chorionic gonadotropin (HCG) market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies.
• Key companies covered as a part of this study includes Merck & Co., Inc., Ferring B.V., Fresenius SE & Co.KGaA, Lupin, Sun Pharmaceutical Industries Ltd, Lee BioSolutions, Serum Institute of India Pvt. Ltd., Scripps Laboratories, Sanzyme Biologics Pvt. Ltd., VHB Medi Sciences Limited, Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global human chorionic gonadotropin (HCG) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human chorionic gonadotropin hormone (HCG) market.

Market Segmentation

• By Product Type
  • Human Chorionic Gonadotropin
  • Recombinant Human Chorionic Gonadotropin
• By Therapeutic Application
  • Male Hypogonadism
  • Female Infertility Treatment
  • Oligospermic Treatment
  • Cryptorchidism Treatment
  • Chronic Pain
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Merck & Co., Inc.
  • Ferring B.V.
  • Fresenius SE & Co.KGaA,
  • Lupin
  • Sun Pharmaceutical Industries Ltd.
  • Lee BioSolutions
  • Serum Institute of India Pvt. Ltd.
  • Scripps Laboratories
  • Sanzyme Biologics Pvt. Ltd.
  • VHB Medi Sciences Limited Bharat Serums
  • Vaccines Limited (BSV)
  • Zydus Lifesciences Ltd
  • Corona Remedies Pvt. Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Therapeutic Application
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • PEST Analysis
  • PORTER's Five Forces Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global Human Chorionic Gonadotropin (HCG) Market, By Product Type, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Human Chorionic Gonadotropin
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Recombinant Human Chorionic Gonadotropin
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

5. Global Human Chorionic Gonadotropin (HCG) Market, By Therapeutic Application, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Male Hypogonadism
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Female Infertility Treatment
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Oligospermic Treatment
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Cryptorchidism Treatment
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Chronic Pain
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Others
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

6. Global Human Chorionic Gonadotropin (HCG) Market, By Distribution Channel, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospital Pharmacies
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Retail Pharmacies
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Online Pharmacies
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

7. Global Human Chorionic Gonadotropin (HCG) Market, By Region, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2033
• North America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis (3x3 Matrix)
• Company Profiles
  • Merck & Co., Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Ferring B.V.,Fresenius SE & Co.KGaA
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Lupin
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Sun Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Lee BioSolutions
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Serum Institute of India Pvt. Ltd
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Scripps Laboratories
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Sanzyme Biologics Pvt. Ltd.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • VHB Medi Sciences Limited Bharat Serums And Vaccines Limited (BSV)
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Zydus Lifesciences Ltd
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Corona Remedies Pvt. Ltd.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates

9. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. Section

• References
• Research Methodology
• About Us and Sales Contact